In this case study, a patient with metastatic melanoma was given multiple lines of chemotherapy that were ineffective. The patient’s oncologist subsequently selected a combination of two targeted drugs that led to a remarkable response. This was done “blindly”, i.e., without any genomic sequencing data from the tumor, based on the experience of the oncologist. This […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.